These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34069585)

  • 1. Nanoformulation Development to Improve the Biopharmaceutical Properties of Fisetin Using Design of Experiment Approach.
    Liu WY; Lin CC; Hsieh YS; Wu YT
    Molecules; 2021 May; 26(10):. PubMed ID: 34069585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and optimization of quercetin-loaded PLGA nanoparticles by experimental design.
    Tefas LR; Tomuţă I; Achim M; Vlase L
    Clujul Med; 2015; 88(2):214-23. PubMed ID: 26528074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
    Feng SS; Mu L; Win KY; Huang G
    Curr Med Chem; 2004 Feb; 11(4):413-24. PubMed ID: 14965222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
    Wang N; Wu XS; Li JK
    Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nose-To-Brain Delivery of PLGA-Diazepam Nanoparticles.
    Sharma D; Sharma RK; Sharma N; Gabrani R; Sharma SK; Ali J; Dang S
    AAPS PharmSciTech; 2015 Oct; 16(5):1108-21. PubMed ID: 25698083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design.
    Zhou YZ; Alany RG; Chuang V; Wen J
    Drug Dev Ind Pharm; 2013 Feb; 39(2):321-30. PubMed ID: 22607101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly (Lactic-Co-Glycolic) Acid-Poly (Vinyl Pyrrolidone) Hybrid Nanoparticles to Improve the Efficiency of Oral Delivery of β-Carotene.
    Liu WY; Hsieh YS; Wu YT
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational design of Phe-Tyr dipeptide and preparation, characterization, cytotoxicity studies of Phe-Tyr dipeptide loaded PLGA nanoparticles for the treatment of hypertension.
    Kecel-Gündüz S; Budama-Kilinc Y; Cakir Koc R; Kökcü Y; Bicak B; Aslan B; Özel AE
    J Biomol Struct Dyn; 2018 Aug; 36(11):2893-2907. PubMed ID: 28835169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement.
    Gera S; Talluri S; Rangaraj N; Sampathi S
    AAPS PharmSciTech; 2017 Nov; 18(8):3151-3162. PubMed ID: 28534300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation.
    Yadav KS; Sawant KK
    Curr Drug Deliv; 2010 Jan; 7(1):51-64. PubMed ID: 20044908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
    Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA
    Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
    Patil GB; Surana SJ
    J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of nanosuspensions and freeze-dried PLGA nanoparticles as a novel approach for ophthalmic delivery of pranoprofen.
    Abrego G; Alvarado HL; Egea MA; Gonzalez-Mira E; Calpena AC; Garcia ML
    J Pharm Sci; 2014 Oct; 103(10):3153-64. PubMed ID: 25091511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation development and in vitro evaluation of gentamicin sulfate-loaded PLGA nanoparticles based film for the treatment of surgical site infection by Box-Behnken design.
    Dhal C; Mishra R
    Drug Dev Ind Pharm; 2019 May; 45(5):805-818. PubMed ID: 30698993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation.
    Mehta AK; Yadav KS; Sawant KK
    Curr Drug Deliv; 2007 Jul; 4(3):185-93. PubMed ID: 17627492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzocaine loaded solid lipid nanoparticles: Formulation design, in vitro and in vivo evaluation of local anesthetic effect.
    Basha M; Abd El-Alim SH; Kassem AA; El Awdan S; Awad G
    Curr Drug Deliv; 2015; 12(6):680-92. PubMed ID: 26138680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entrapment and release kinetics of furosemide from pegylated nanocarriers.
    Youm I; Murowchick JB; Youan BB
    Colloids Surf B Biointerfaces; 2012 Jun; 94():133-42. PubMed ID: 22386795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
    Das S; Ng WK; Kanaujia P; Kim S; Tan RB
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable nanoparticles from prosopisylated cellulose as a platform for enhanced oral bioavailability of poorly water-soluble drugs.
    Kenechukwu FC; Dias ML; Ricci-Júnior E
    Carbohydr Polym; 2021 Mar; 256():117492. PubMed ID: 33483021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.